CAPORALI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 6.608
EU - Europa 4.753
AS - Asia 3.537
OC - Oceania 11
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 14.922
Nazione #
US - Stati Uniti d'America 6.547
CN - Cina 3.464
IE - Irlanda 1.572
UA - Ucraina 894
FI - Finlandia 736
DE - Germania 501
SE - Svezia 427
IT - Italia 289
GB - Regno Unito 169
FR - Francia 82
CA - Canada 57
IN - India 32
AT - Austria 26
BE - Belgio 26
AU - Australia 10
IR - Iran 10
RU - Federazione Russa 9
NL - Olanda 8
TR - Turchia 8
JP - Giappone 7
KR - Corea 5
MU - Mauritius 5
EU - Europa 4
HU - Ungheria 4
IQ - Iraq 3
RO - Romania 3
DO - Repubblica Dominicana 2
LV - Lettonia 2
PL - Polonia 2
SA - Arabia Saudita 2
SG - Singapore 2
ZM - Zambia 2
AM - Armenia 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 14.922
Città #
Dublin 1.569
Chandler 1.470
Jacksonville 1.277
Nanjing 1.061
Ashburn 479
Nanchang 425
Princeton 359
Lawrence 327
Wilmington 319
Changsha 305
Shenyang 305
Hebei 304
Medford 244
Beijing 237
Jiaxing 230
Helsinki 220
Hangzhou 167
Ann Arbor 161
Tianjin 159
Boardman 136
Milan 87
Woodbridge 80
Shanghai 71
New York 69
Norwalk 64
Pavia 62
Verona 48
Toronto 39
Fairfield 35
Seattle 33
Brussels 26
Los Angeles 25
Jinan 24
Vienna 24
Houston 19
Ningbo 19
Washington 19
Kunming 18
Zhengzhou 18
Des Moines 15
San Francisco 15
Auburn Hills 14
Orange 14
Pune 13
Taizhou 13
Lanzhou 12
Falls Church 11
Guangzhou 10
Fuzhou 9
Tappahannock 8
Dearborn 7
Berlin 6
Borås 6
Changchun 6
Redwood City 6
Rome 6
Canberra 5
Ottawa 5
Settimo Torinese 5
Chicago 4
Haikou 4
Leawood 4
London 4
Redmond 4
Reggio Emilia 4
Walnut 4
Budapest 3
Campi Bisenzio 3
Genoa 3
Honcho 3
Sona 3
Zanjan 3
Andover 2
Atlanta 2
Bexleyheath 2
Bulgorello 2
Busto Arsizio 2
Canyon Country 2
Caronno Pertusella 2
Conegliano 2
Davis 2
Esslingen am Neckar 2
Florence 2
Fremont 2
Genova 2
Groningen 2
Hyderabad 2
Lancaster 2
Las Vegas 2
Lodi 2
Lviv 2
Melbourne 2
Menlo Park 2
Molare 2
Monzambano 2
Riyadh 2
Sacramento 2
Santo Domingo 2
Singapore 2
Tokyo 2
Totale 10.822
Nome #
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 89
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. 87
Interessamento cutaneo nella dermatomiosite 84
Association between anti-dsDNA titre increase and thymoma relapse 78
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 78
Antibodies to cyclic citrullinated peptides in psoriatic arthritis. 78
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 77
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 76
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 75
Cyclophosphamide plus granulocyte colony stimulating factor (G-CSF) is more 75
B cells in rheumatoid arthritis. 75
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 74
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 74
Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients 73
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. 72
Shrinking lung syndrome in sistemic sclerosis 72
Spondiliti e spondilodisciti batteriche. 71
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 70
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse. 69
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 69
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 69
Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry 69
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. 68
Iron Status In Stills Disease 68
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 68
Prednisone plus Methotrexate for polymyalgia rheumatica. A randomized, double blind, placebo-controlled trial. 68
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis 68
Safety of Tumor Necrosis Factor alpha Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative/Anti-Hepatitis B Core Antigen Positive) With Rheumatic Diseases 67
Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria 67
DMARDS and infections in rheumatoid arthritis 67
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 66
Influenza may influence rheumatoid arthritis 66
Safety of Mud-Bath Applications in Moderately Active Rheumatoid Arthritis 65
Autoimmunity in thrombotic thrombocytopenic purpura 65
Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis 65
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 65
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 65
Mature antigen-experienced helper T cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of rheumatoid joint 65
Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response 65
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal 64
Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of wong's dermatomyositis 64
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 63
Comment on: parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's Syndrome. 63
Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical 62
La terapia delle vasculiti necrotizzanti 62
Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine 62
Diffuse skin reaction after changing the etanercept formulation. Clin Exp Rheumatol. 62
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 62
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 62
B cells in rheumatoid arthritis. 62
Efficacy and safety of anti-TNF-alpha therapy combined withcyclosporine a in patients with rheumatoid arthritis and concomitant hepatitis C virus infection. 61
Anti-phospholipid Antibodies and Thrombotic Thrombocytopenic Purpura 60
Overuse of prescription and otc non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis. 60
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 60
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 59
Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes 59
Analysis of pharmacologic and nonpharmacologic prescription patterns of general practitioners and specialists in the AMICA study. 59
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis. 58
La poliangioite microscopica. 58
Long term treatment of rheumatoid arthritis with rituximab 58
Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol 58
Nuovi aspetti patogenetici dell’artrite reumatoide 58
TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. 58
Disease-related malnutrition in systemic sclerosis: Evidences and implications 58
Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis 58
Cyclosporine in addition to infliximab andmethotrexate in refractory rheumatoid arthritis 57
Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use 57
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 57
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 57
What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated peptide antibodies? 56
Serum Bone Gla-protein and Corticosteroids 56
Osteoarthritis: An overview of the disease and its treatment strategies 56
High Prevalence of Antiphospholipid Antibodies In Children With Idiopathic Cerebral-ischemia 56
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: Long-term real-life data from the Lorhen registry 56
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 56
A case of adult onset Still's disease treated with infliximab - Reply 56
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. 55
Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids 55
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 55
Anti-ssb/la Antibodies In Sjogrens Syndrome and Related Autoimmune-diseases - Results of A Quantitative Immunoassay Using A Highly Purified Antigen 55
Rheumatoid arthritis and renal light-chain deposition disease: long-term effectiveness of TNF-alpha blockade with etanercept 55
Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis 55
Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. 55
Therapeutic options in Anti-Jo1 antisynthetase syndrome with interstitial lung disease. 55
Switching TNF-alpha antagonists in rheumatoid arthritis: The experience of the LORHEN registry 54
Compressive cervical myelopathy due to massive periodontoid calcium pyrophosphate crystal deposition 54
Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. 54
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN). 54
Anticardiolipin Antibodies In Pediatric Systemic Lupus-erythematosus 54
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety 54
In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis. 54
Disease-related malnutrition in outpatients with systemic sclerosis. 54
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. 54
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis 54
Treatment comparison in rheumatoid arthritis: Head-to-head trials and innovative study designs 54
Fetal programming and systemic sclerosis 54
Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis 54
Cardiovascular effects of coxibs 53
Sex-hormones and Bone Metabolism In Postmenopausal Rheumatoid-arthritis Treated With 2 Different Glucocorticoids 53
Hematological Abnormalities Associated With Anticardiolipin Antibodies 53
Totale 6.273
Categoria #
all - tutte 54.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 0 0 8 13
2019/20204.073 1.242 1.778 5 166 5 186 22 191 32 312 130 4
2020/20211.819 188 149 67 163 2 249 19 292 82 305 234 69
2021/20221.349 31 6 32 14 18 38 44 99 66 20 207 774
2022/20234.426 532 295 37 266 465 466 2 260 1.875 33 116 79
2023/20241.396 169 339 63 115 156 381 16 98 10 49 0 0
Totale 15.405